IPCA Laboratories Quarterly Results for Trading Insights
IPCALAB • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹281 Cr
QSept 2025
IPCA Laboratories Quarterly Results Key Highlights
- Revenue of ₹2,584 Cr in Sept 2025 (+13.7% vs Mar 2025, +8.5% vs Sept 2024)
- Net Profit of ₹281 Cr in Sept 2025 (+339.1% vs Mar 2025, +14.2% vs Sept 2024)
- EBITDA of ₹515 Cr in Sept 2025 (+106.0% vs Mar 2025)
- Operating Margin of 19.0% in Sept 2025 (+9.0pp vs Mar 2025)
- Earnings Per Share of ₹11.14 in Sept 2025 (+317.2% vs Mar 2025)
IPCA Laboratories Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 2,584 | 2,273 | 2,342 | 2,381 | 2,052 | 13.7% | 8.5% |
| Net Profit (₹ Cr) | 281 | 64 | 233 | 246 | 1 | - | - |
| EBITDA (₹ Cr) | 515 | 250 | 449 | 468 | 204 | - | - |
| EPS (₹) | 11.14 | 2.67 | 9.19 | 9.05 | 2.35 | - | - |
| Operating Margin (%) | 19.0% | 10.0% | 18.0% | 19.0% | 9.0% | - | - |
IPCA Laboratories Share Price Trend Around Quarterly Results
Visualize IPCA Laboratories's 1-year price movement across quarterly results — ideal for logging trades in IPCA Laboratories share price
chart using Tickjournal. All values in ₹.
Related Pages for IPCA Laboratories
Additional stock information and data for IPCALAB
Revenue Trend (₹ Cr)
Sept 2024
2,381
Jun 2025
2,342
Mar 2025
2,273
Sept 2025
2,584
Net Profit Trend (₹ Cr)
Sept 2024
246
Jun 2025
233
Mar 2025
64
Sept 2025
281
Operating Margin Trend (%)
Sept 2024
19.0%
Jun 2025
18.0%
Mar 2025
10.0%
Sept 2025
19.0%
Sector Competitors - Quarterly Performance Comparison
Comparing IPCA Laboratories quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹417,052.40 Cr | 1729.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 133.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6616.5 | 2,860 | 689 | +7.1% | - | 24.1% | 254.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3963.4 | 3,219 | 591 | +11.3% | - | 18.4% | 226.0 |
|
Cipla
Sept 2025 |
₹118,572.82 Cr | 1465.7 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹100,998.62 Cr | 1210.1 | 9,135 | 1,337 | +1.1% | - | 14.6% | 74.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores